Siemens Healthineers AG (SEMHF)
55.51
+0.35
(+0.63%)
USD |
OTCM |
Sep 19, 16:00
Siemens Healthineers Enterprise Value: 60.47B for Sept. 19, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 19, 2024 | 60.47B |
| September 18, 2024 | 60.08B |
| September 17, 2024 | 60.08B |
| September 16, 2024 | 63.24B |
| September 13, 2024 | 63.24B |
| September 12, 2024 | 63.24B |
| September 11, 2024 | 63.24B |
| September 10, 2024 | 63.24B |
| September 09, 2024 | 63.24B |
| September 06, 2024 | 63.24B |
| September 05, 2024 | 63.24B |
| September 04, 2024 | 63.24B |
| September 03, 2024 | 63.24B |
| August 30, 2024 | 63.24B |
| August 29, 2024 | 62.91B |
| August 28, 2024 | 62.91B |
| August 27, 2024 | 64.32B |
| August 26, 2024 | 60.39B |
| August 23, 2024 | 60.39B |
| August 22, 2024 | 60.39B |
| August 21, 2024 | 60.39B |
| August 20, 2024 | 60.39B |
| August 19, 2024 | 61.58B |
| August 16, 2024 | 61.58B |
| August 15, 2024 | 61.58B |
| Date | Value |
|---|---|
| August 14, 2024 | 59.84B |
| August 13, 2024 | 59.84B |
| August 12, 2024 | 59.84B |
| August 09, 2024 | 59.84B |
| August 08, 2024 | 62.54B |
| August 07, 2024 | 62.54B |
| August 06, 2024 | 62.54B |
| August 05, 2024 | 62.54B |
| August 02, 2024 | 62.54B |
| August 01, 2024 | 62.54B |
| July 31, 2024 | 62.54B |
| July 30, 2024 | 62.54B |
| July 29, 2024 | 62.54B |
| July 26, 2024 | 62.54B |
| July 25, 2024 | 62.54B |
| July 24, 2024 | 62.54B |
| July 23, 2024 | 62.54B |
| July 22, 2024 | 62.54B |
| July 19, 2024 | 62.54B |
| July 18, 2024 | 62.54B |
| July 17, 2024 | 62.54B |
| July 16, 2024 | 62.54B |
| July 15, 2024 | 62.54B |
| July 12, 2024 | 62.54B |
| July 11, 2024 | 62.81B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
32.82B
Minimum
Mar 18 2020
85.63B
Maximum
Dec 31 2021
58.14B
Average
58.94B
Median
Aug 04 2023
Enterprise Value Benchmarks
| Affimed NV | 34.35M |
| InflaRx NV | 10.30M |
| BioNTech SE | 8.485B |
| Immatics NV | 685.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 505.00M |
| Revenue (Quarterly) | 5.839B |
| Total Expenses (Quarterly) | 5.108B |
| EPS Diluted (Quarterly) | 0.4522 |
| Gross Profit Margin (Quarterly) | 38.54% |
| Profit Margin (Quarterly) | 8.65% |
| Earnings Yield | 3.24% |
| Operating Earnings Yield | 4.72% |
| Normalized Earnings Yield | 3.237 |